首页 > 市场调查报告书 > 医疗设备

药物递输设备

胰岛素输注装置市场规模、份额及成长分析（依产品类型、糖尿病类型、最终用户及地区划分）－2025-2032年产业预测

市场调查报告书

商品编码

1865314

胰岛素输注装置市场规模、份额及成长分析（依产品类型、糖尿病类型、最终用户及地区划分）－2025-2032年产业预测

Insulin Delivery Devices Market Size, Share, and Growth Analysis, By Product Type (Insulin Pens, Insulin Pumps (Tethered)), By Diabetes Type (Type 1 Diabetes, Type 2 Diabetes), By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年11月07日 | 出版商:

SkyQuest | 英文 184 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2023 年，全球胰岛素输送设备市场规模将达到 167 亿美元，到 2024 年将达到 180.2 亿美元，到 2032 年将达到 331.1 亿美元，预测期（2025-2032 年）的复合年增长率为 7.9%。

由于糖尿病盛行率不断上升，全球胰岛素输注设备市场正经历显着成长。这种需求的激增推动了先进、便利的糖尿病管理系统的发展。数位技术，特别是持续血糖监测（CGM）系统的应用，透过基于持续血糖值监测结果即时调整胰岛素剂量，提高了胰岛素输注的效率。此外，穿戴式和贴片式胰岛素帮浦也越来越受欢迎，它们能够以隐藏便捷的方式持续输注胰岛素。该领域的创新，例如尖端贴片式胰岛素帮浦系统的新应用，凸显了技术的不断进步，进一步推动了市场扩张，并改善了患者的糖尿病管理体验。

全球胰岛素输注设备市场驱动因素

全球胰岛素输注设备市场的主要驱动力在于一个可互通生态系统的兴起，该生态系统将胰岛素输注系统与持续血糖监测仪 (CGM)、智慧型手机应用程式、智慧胰岛素笔和连网胰岛素帮浦整合在一起。这种整合提高了给药精度，增强了患者对治疗方案的依从性，并方便医护人员进行远端监测，从而降低了低血糖事件的发生频率，减少了患者就诊次数。此外，远距远端医疗和数位糖尿病管理计画的报销机会不断扩大，也推动了连网设备在居家照护和门诊环境中的应用，增强了临床医生的信心，并让患者更加安心。

全球胰岛素输送装置市场阻碍因素

全球胰岛素输注设备市场面临许多挑战，其中设备及其耗材（尤其是自动胰岛素帮浦和整合系统）的高成本限制了价格敏感地区的普及。不同地区的健保报销政策差异进一步阻碍了这些技术的推广，导致在医保覆盖范围有限的情况下，推广速度更为缓慢。支付方不愿核准诸如贴片式胰岛素帮浦和封闭回路型系统等新兴技术，也构成了市场准入的障碍。为了扩大健保覆盖范围并降低成本，製造商必须证明其产品的价值和可行性，才能获得医保支付方的必要支援。

全球胰岛素注射装置市场趋势

紧凑型无导管贴片式胰岛素帮浦的普及是全球胰岛素输注设备市场的一大趋势，反映出使用者对简单易用解决方案的偏好。这些创新系统简化了胰岛素给药流程，并提高了糖尿病患者的生活品质。随着技术进步，智慧型手机控制和自动化演算法的应用日益普及，这些设备也变得越来越受欢迎，尤其受到那些对传统胰岛素帮浦犹豫不决的患者的青睐。这项变化不仅有助于改善糖尿病管理，也标誌着整个市场正朝着以患者为中心、更人性化的胰岛素输注方式转变。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2024 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2024 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2022-2024年营收年比比较

主要企业简介

Medtronic plc
Insulet Corporation
Novo Nordisk A/S
Sanofi
Eli Lilly and Company
Ypsomed AG
B. Braun SE
Owen Mumford Ltd.
BD（Becton, Dickinson and Company）
Tandem Diabetes Care, Inc.
Roche Holding AG（Diabetes Care Division）
Abbott Laboratories（Diabetes Care）
Johnson & Johnson（Diabetes Solutions）
Dexcom, Inc.（Integrated pump solutions）
Ascensia Diabetes Care Holdings AG
SOOIL Development Co., Ltd.
Nippon Boehringer Ingelheim Co., Ltd.
Terumo Corporation
AgaMatrix
Omron Healthcare Co., Ltd.

结论与建议

简介目录

Product Code: SQMIG35B2261

Global Insulin Delivery Devices Market size was valued at USD 16.7 billion in 2023 and is poised to grow from USD 18.02 billion in 2024 to USD 33.11 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The global market for insulin delivery devices is experiencing significant growth driven by the rising prevalence of diabetes. This surge in demand is prompting the development of advanced, user-friendly diabetes management systems. The integration of digital technologies, particularly Continuous Glucose Monitoring (CGM) systems, is enhancing insulin delivery by enabling real-time adjustments of insulin doses based on continuous blood glucose monitoring. Additionally, wearable and patch insulin pumps are gaining traction, offering discreet and convenient methods for administering continuous insulin infusion. Innovations in this sector, such as new applications for cutting-edge patch insulin pump systems, highlight the ongoing advancements in technology, further propelling market expansion and improving patient experiences in diabetes management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Delivery Devices Market Segments Analysis

Global Insulin Delivery Devices Market is segmented by Product Type, Diabetes Type, End-User and region. Based on Product Type, the market is segmented into Insulin Pens, Insulin Pumps (Tethered), Insulin Pumps (Tubeless / Patch), Insulin Syringes & Needles and Smart Insulin Delivery Devices. Based on Diabetes Type, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other Special Populations. Based on End-User, the market is segmented into Home Care / Self-administration, Hospitals & Clinics and Specialized Diabetes Care Centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Delivery Devices Market

The global market for insulin delivery devices is being significantly propelled by the emergence of interoperable ecosystems that integrate insulin delivery systems with continuous glucose monitors (CGMs), smartphone applications, smart pens, and connected pumps. This integration enhances dosing precision, bolsters patient adherence to treatment plans, and facilitates remote monitoring by healthcare providers, thereby reducing the frequency of hypoglycemic events and lowering hospital visits. Additionally, growing reimbursement opportunities for telehealth and digital diabetes management programs are paving the way for more connected devices within home care and outpatient settings, fostering greater confidence among clinicians and promoting a sense of comfort for patients.

Restraints in the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market faces significant challenges due to the high costs associated with devices and their consumables, especially with automated pumps and integrated systems, which limits accessibility for price-sensitive regions. Variations in reimbursement policies across different regions further impede the adoption of these technologies, resulting in delays when coverage is restricted. This reluctance from payers to endorse emerging technologies, such as patch pumps and closed-loop systems, poses barriers to market entry. For broader coverage and affordability, manufacturers must demonstrate the value and feasibility of their offerings to gain the necessary support from healthcare payers.

Market Trends of the Global Insulin Delivery Devices Market

The global insulin delivery devices market is witnessing a significant trend towards the adoption of smaller, tubeless patch pumps, reflecting a user preference for streamlined and convenient solutions. These innovative systems simplify insulin administration, thereby enhancing the quality of life for diabetic patients. As advancements in technology lead to the incorporation of smartphone controls and automated algorithms, the appeal of these devices is growing, particularly among individuals hesitant to use traditional pumps. This shift not only supports better management of diabetes but also indicates a broader movement within the market towards more patient-centric, user-friendly insulin delivery methods.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Assessment
Regulatory Landscape

Global Insulin Delivery Devices Market Size by Product Type & CAGR (2025-2032)

Market Overview
Insulin Pens
Insulin Pumps (Tethered)
Insulin Pumps (Tubeless / Patch)
Insulin Syringes & Needles
Smart Insulin Delivery Devices

Global Insulin Delivery Devices Market Size by Diabetes Type & CAGR (2025-2032)

Market Overview
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Other Special Populations

Global Insulin Delivery Devices Market Size by End-User & CAGR (2025-2032)

Market Overview
Home Care / Self-administration
Hospitals & Clinics
Specialized Diabetes Care Centres

Global Insulin Delivery Devices Market Size & CAGR (2025-2032)

North America (Product Type, Diabetes Type, End-User)
- US
- Canada
Europe (Product Type, Diabetes Type, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Diabetes Type, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Diabetes Type, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Diabetes Type, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Diabetes Care Division)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (Diabetes Care)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (Diabetes Solutions)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (Integrated pump solutions)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ascensia Diabetes Care Holdings AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SOOIL Development Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nippon Boehringer Ingelheim Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omron Healthcare Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments